research use only
Cat.No.P1127
Amino-acid Sequence
CAS No. 396091-73-9
Selleck's Pasireotide Has Been Cited by 2 Publications
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Storage (From the date of receipt) | 3 years-20°C powder | ||
|
In vitro |
DMSO
: 100 mg/mL
(95.49 mM);
Ethanol : 100 mg/mL Water : Insoluble |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | Pasireotide (SOM230) is a multi-receptor ligand somatostatin analogue with high binding affinity for somatostatin receptor (SSTR) subtypes sst1,2,3 and sst5. It potently suppresses GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing’s disease. |
|---|---|
| Targets/IC50/Ki |
SST2
|
References |
|
| Molecular Formula | C58H66N10O9 |
|---|---|
| Molecular Weight | 1047.21 |
| CAS No. | 396091-73-9 |
| Appearance | White Powder |
| Peptide Content (by %N) | ≥80% |
| Single Impurity (by HPLC) | ≤1.0% |
| Assay (By Anhydrous, Acetic Acid-free) | 95.0~105.0% |
| MS | Consistent |
| Packing | plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. |
| Storage (From the date of receipt) |
3 years-20°C powder |
| Shipping | Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.) |